Bruker Corp. entered a definitive agreement to acquire Chemspeed Technologies AG, a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research for cleantech and consumer applications. Financial details were not disclosed. In 2023, Chemspeed generated revenues greater than $50 million.
 
The acquisition adds lab automation, digitalization and scientific software solutions designed to enhance productivity in R&D and QC departments. Chemspeed complements Bruker’s vendor-agnostic platform SciY for software automation and digital transformation of R&D labs in the life science, biopharma and cleantech industries.
 
Chemspeed offers a portfolio of flexible automation modules, ranging from bench-top workstations to integrated automated R&D workflows. Chemspeed also offers compliance-ready workflow solutions to automate and digitalize R&D and QC in regulated environments, to help ensure data integrity, traceability, and quality.
 
Dr. Rolf Gueller, the founder and CEO of Chemspeed, said, “Our team is excited to join Bruker to further boost automated and digitalized workflows for our customers. With decades of experience in automating R&D workflows, our modular solutions accelerate developments, allowing lab technicians and scientists to focus on their core competencies and creativity.” Going forward, Dr. Gueller is expected to contribute to Chemspeed customers’ success on the Chemspeed Advisory Board.
 
Dr. Falko Busse, the President of the Bruker BioSpin Group, said, “Chemspeed’s scalable modularity and flexibility demonstrate what is achievable today in lab automation to customize workflows, integrate automation layers with efficient workflow and data management. We are excited to welcome the experienced team of Chemspeed to Bruker. Their commitment to excellence is reflected in the wide range of Chemspeed automation, and their dedication to customer service.”